Dark

CNTX
Context Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Nov 17, 2025 3:59:30 PM EST

1.16USD-0.431%(-0.01)191,398

1.14Bid 1.16Ask 0.02Spread

Pre-market

Nov 17, 2025 8:51:30 AM EST

1.18USD+1.724%(+0.02)100

After-hours

Nov 14, 2025 4:44:30 PM EST

1.16USD-0.846%(-0.01)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

106.12M

Headquarters

Philadelphia, Pennsylvania, USA

Industry

Biotechnology

Next Earnings

Mar 25, 2026 (127d)

CNTX Stats

Avg. Vol. 10 Day

200,207

Avg. Vol. 30 Day

427,721

Market Cap

106,120,449

Shares Out.

91,879,177

On/Off Exchange

35%/65%

6 Month Beta

1.36

1 Year Beta

1.08

2 Year Beta

0.95

3 Year Beta

1.12

52 Week Low

0.49

52 Week High

1.84

SMA50

1.10

SMA200

0.85

1 Week

-4.52%

1 Month

-19.79%

3 Month

+32.41%

6 Month

+62.27%

1 Year

-31.25%

2 Year

+15.50%

5 Year

-77.35%

Profile

context therapeutics is dedicated to discovering, acquiring, and developing novel compounds to treat hormone responsive cancers. our lead program is apristor (onapristone xr), an investigational drug for progesterone receptor positive (pr+) breast cancer. up to 70% of breast cancers express progesterone receptor (pr). if your cancer is pr+, apristor could be an option for you.

CNTX Stock Summary

Context Therapeutics Inc. Common Stock (NASDAQ:CNTX) stock price today is $1.16, and today's volume is 191,398. CNTX is down -0.431% today. The 30 day average volume is 427,721. CNTX market cap is 106.12M with 91,879,177 shares outstanding.

.dark-mode .BWPQrB{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .BWPQrB{ color: #333333; background-color: white; border: 2px solid #333333; }CNTXContext Therapeutics Inc. Common Stockstock NASDAQ

CNTX Stock Summary

CNTX
Context Therapeutics Inc. Common Stock
stock NASDAQ